Heat Biologics, Inc.
AMEX: HTBX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- New York Stock Exchange Arca
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Jeffrey Wolf
- Employees
- 49
- Headquarters
- Morrisville, United States
- IPO year
- 2013
- Market cap
- $61.1M
- Website
- https://www.heatbio.com
Loading HTBX…
Loading profile data…Frequently asked questions about HTBX
What does Heat Biologics, Inc. (HTBX) do?
Heat Biologics, Inc. is an integrated biopharmaceutical company focused on creating immune-modulating therapies and vaccines. The firm's primary goal is to harness the immune system to fight a variety of illnesses, including both cancerous growths and infectious diseases. A cornerstone of their approach is the gp96 platform, which comprises two...
Where does HTBX trade?
Heat Biologics, Inc. (HTBX) trades on the New York Stock Exchange Arca.
What sector is HTBX in?
Heat Biologics, Inc. (HTBX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Heat Biologics, Inc.?
Jeffrey Wolf is the chief executive officer of Heat Biologics, Inc. (HTBX).
Where is Heat Biologics, Inc. headquartered?
Heat Biologics, Inc. is headquartered in United States.
Does HTBX pay a dividend?
Heat Biologics, Inc. (HTBX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did HTBX go public?
Heat Biologics, Inc. (HTBX) completed its initial public offering in 2013.